Abacus Life and Lorisco Life announced a new partnership and product launch to revolutionize longevity-based health prediction and actuarial technology. “We are proud to be partnering with Abacus Life to enable how health predictions are customized for end users through proteomics and machine learning,” said Howard Sams, Lorisco Life Chief Executive Officer. “The PREADISAN risk score enables the Abacus team to offer an unprecedented level of tailored solutions for their clients.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABL:
- Abacus Life and Lorisco Life Announce Launch of PREADISAN™ to Improve Health Predictions
- Abacus Life reports Q2 adjusted EPS 18c, consensus 13c
- Abacus Life Awards CFO McCauley a $200K Bonus
- Abacus Life Announces Strategic Acquisition of FCF Advisors
- Abacus Life to acquire FCF Advisors, terms undisclosed